Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

1 structures for Q8XRL7

Entry ID Method Resolution Chain Position Source
AF-Q8XRL7-F1 Predicted AlphaFoldDB

No variants for Q8XRL7

Variant ID(s) Position Change Description Diseaes Association Provenance
No variants for Q8XRL7

No associated diseases with Q8XRL7

No regional properties for Q8XRL7

Type Name Position InterPro Accession
No domain, repeats, and functional sites for Q8XRL7

Functions

Description
EC Number 1.1.5.4 With a quinone or similar compound as acceptor
Subcellular Localization
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

No GO annotations of cellular component

Name Definition
No GO annotations for cellular component

2 GO annotations of molecular function

Name Definition
malate dehydrogenase (menaquinone) activity Catalysis of the reaction: (S)-malate + a menaquinone = oxaloacetate + a menaquinol.
malate dehydrogenase (quinone) activity Catalysis of the reaction: (S)-malate + a quinone = oxaloacetate + a quinol.

1 GO annotations of biological process

Name Definition
tricarboxylic acid cycle A nearly universal metabolic pathway in which the acetyl group of acetyl coenzyme A is effectively oxidized to two CO2 and four pairs of electrons are transferred to coenzymes. The acetyl group combines with oxaloacetate to form citrate, which undergoes successive transformations to isocitrate, 2-oxoglutarate, succinyl-CoA, succinate, fumarate, malate, and oxaloacetate again, thus completing the cycle. In eukaryotes the tricarboxylic acid is confined to the mitochondria. See also glyoxylate cycle.

No homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
No homologous proteins
10 20 30 40 50 60
MVCLAAFSAQ AAETKKVDVL LVGGGIMSST LGVWLHELEP DWSMMMVERL DGVAQESSNG
70 80 90 100 110 120
WNNAGTGHSA LAELNYTPEK SNGKIDISKA VEINEGFQVT RQFWTYQVKT GVLKNPRSFI
130 140 150 160 170 180
NSTPHMSFVW GEDNVRYLKK RYEALQASPL FRGMQFSDDY DQISKWVPLM MEGRDRSQKV
190 200 210 220 230 240
AATWMPVGTD VNFGEITRQF VGYLQSQPQF TLSLSSEVRD IKRNDDGTWR VSYVNLKSGD
250 260 270 280 290 300
RQDVDTKFLF IGAGGGALRL LQASGIPEAR DFAAFPVGGS FLVTENPEVV NRHLAKAYGK
310 320 330 340 350 360
ASVGSPPMSV PHLDTRVIDG KRIILFGPFA TFSTKFLKNG SYMDLFGSTT SHNVMPMLHV
370 380 390 400 410 420
GVDEFPLVQY LAGQLMLSDE DRFNALKEYF PLAKKEDWRL WQAGQRVQII QRDEAKGGIL
430 440 450 460 470 480
KLGTQIVKSK DGTIAGLLGA SPGASTAAPI MLGVLETVFK DKLATPAWQQ KVRQMIPTYG
490 500 510 520 530 540
IKLNDNPAKV YEEWVATAEA LQLSPPPRID LRVTPAAPAA KPAAGAAQQA KPAKATADIA
L